Large-scale testing (Phase 3)Study completedNCT00309699
What this trial is testing
Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder
Who this might be right for
Bipolar DisorderMood Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 493